IL18BP and lobular neoplasia: reported significantly elevated plasma IL-18 (767.0 ± 133.5 pg/ml vs. 238.9 ± 64.4 pg/ml, p < 0.01) and IL-18BP (8.0 ± 3.0 ng/ml vs. 5.6 ± 2.1 ng/ml, p < 0.05) levels in LN patients compared with healthy controls (14).